To compare the efficacy of deep brain stimulation (DBS) and MRI-guided
focused ultrasound (MRIgFUS) in parkinsonian tremor. We performed a network
meta-analysis based on a Bayesian framework. We searched the literature for
articles published between January 1990 and October 2020 using three databases:
PubMed, Embase and Cochrane Library (The Cochrane Database of Systematic Reviews).
A total of 24 studies were included in our analysis, comprising data from 784
participants. Our findings revealed similar efficacy of DBS and MRIgFUS in
parkinsonian tremor suppression. Compared with internal globus pallidus
(GPi)-MRIgFUS, GPi-DBS -1.84 (–6.44, 2.86), pedunculopontine nucleus (PPN)_DBS
–3.28 (–9.28, 2.78), PPN and caudal zona incerta (cZI)-DBS 0.40 (–6.16, 6.87),
subthalamic nucleus (STN)_DBS 0.89 (–3.48, 5.30), STN and cZI-DBS 1.99 (–4.74,
8.65), ventral intermediate nucleus(VIM)_DBS 1.75 (–2.87, 6.48), VIM_FUS 0.72
(–5.27, 6.43), cZI-DBS 0.27 (–4.75, 5.36) were no significantly difference.
Compared with VIM-MRIgFUS, GPi-DBS -2.55(-6.94, 2.21), GPi-FUS -0.72 (–6.43,
5.27), PPN_DBS -4.01(–9.97, 2.11), PPN and cZI-DBS -0.32 (-6.73, 6.36), STN_DBS
0.16 (–3.98, 4.6), STN and cZI-DBS 1.31(-5.18,7.87), VIM-DBS 1.00(-3.41, 5.84)and
cZI-DBS –0.43 (–5.07, 4.68) were no significantly difference. With respect to the
results for the treatment of motor symptoms, GPi-DBS, GPi-MRIgFUS, STN-DBS and
cZI-DBS were significantly more efficacious than baseline (GPi-DBS 15.24 (5.79,
24.82), GPi-MRIgFUS 13.46 (2.46, 25.10), STN-DBS 19.62 (12.19, 27.16), cZI-DBS
14.18 (1.73, 26.89). The results from the surface under the cumulative ranking
results showed that STN-DBS ranked first, followed by combined PPN and cZI-DBS,
and PPN-DBS ranked last. MRIgFUS, an efficacious intervention for improving
parkinsonian tremor, has not demonstrated to be inferior to DBS in parkinsonian
tremor suppression. Hence, clinicians should distinguish individual patients’
symptoms to ensure that the appropriate intervention and therapeutic approach are
applied.